What is Anaptysbio, Inc worth?
With the base-case assumptions below, a discounted cash flow model on Anaptysbio, Inc's reported free cash flow gives $29.65 per share. The share price was $51.00 on September 25, 2026, 72% above that value.
Inputs from the filings
Three sets of assumptions
| Case | Growth yrs 1-5 | Discount rate | Value per share | Value vs price |
|---|---|---|---|---|
| Bear | 10.0% | 10.0% | $21.24 | -58% |
| Base | 15.0% | 9.0% | $29.65 | -42% |
| Bull | 20.0% | 8.0% | $45.31 | -11% |
Sensitivity: base case value per share
| 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | |
|---|---|---|---|---|---|
| 7.0% | $36.02 | $38.00 | $40.43 | $43.46 | $47.36 |
| 8.0% | $31.23 | $32.52 | $34.04 | $35.87 | $38.10 |
| 9.0% | $27.75 | $28.63 | $29.65 | $30.83 | $32.23 |
| 10.0% | $25.11 | $25.74 | $26.45 | $27.26 | $28.20 |
| 11.0% | $23.05 | $23.51 | $24.02 | $24.60 | $25.25 |
Where the presets come from
Base: years 1 to 5 grow at Anaptysbio, Inc's revenue growth rate over the last 5 fiscal years (25.6% a year), held between -5% and 15%. Years 6 to 10 grow halfway between that and the long-run rate of 2.5%. Future cash is discounted at 9% a year.
Bear: 5 points less growth, 2% long-run growth, 10% discount rate. Bull: 5 points more growth (at most 25%), 3% long-run growth, 8% discount rate.
Value per share = (present value of 10 years of free cash flow + present value of everything after + cash - debt) / diluted shares.
This is a model run on assumptions, not a recommendation or a price target. Small changes in the discount rate or growth move the result a lot, as the table above shows. Change them yourself in the calculator.
Adjust the assumptions
Move the sliders for growth, long-run growth and discount rate, or switch to average free cash flow, and see the value per share change.
Adjust the assumptions